| Net earnings (loss) |
745M |
| Other charges (gains), net of amounts used |
| Depreciation, amortization and accretion |
223M |
| Deferred income taxes, net |
39M |
| (Gain) loss on disposition of businesses and assets, net |
1M |
| Refinancing expense |
| Value-added tax on deferred proceeds from Ticona Kelsterbach plant relocation |
| Other, net |
| Operating cash provided by (used in) discontinued operations |
0 |
| Trade receivables - third party and affiliates, net |
-82M |
| Inventories |
36M |
| Other assets |
53M |
| Trade payables - third party and affiliates |
16M |
| Other liabilities |
-50M |
| Net cash provided by (used in) operating activities |
940M |
| Capital expenditures on property, plant and equipment |
-186M |
| Acquisitions, net of cash acquired |
0 |
| Proceeds from sale of businesses and assets, net |
8M |
| Deferred proceeds from Ticona Kelsterbach plant relocation |
| Capital expenditures related to Ticona Kelsterbach plant relocation |
| Other, net |
-14M |
| Net cash provided by (used in) investing activities |
-192M |
| Short-term borrowings (repayments), net |
-347M |
| Proceeds from long-term debt |
1.51B |
| Repayments of long-term debt |
-1.1B |
| Refinancing costs |
| Purchases of treasury stock, including related fees |
-300M |
| Stock option exercises |
3M |
| Series A common stock dividends |
-150M |
| Preferred stock dividends |
| Other, net |
-35M |
| Net cash provided by (used in) financing activities |
-467M |
| Exchange rate effects on cash and cash equivalents |
4M |
| Net increase (decrease) in cash and cash equivalents |
285M |
| Cash and cash equivalents at beginning of period |
967M |
| Cash and cash equivalents at end of period |
1.25B |
